Publication:
COVID-19 pneumonia and idiopathic pulmonary fibrosis: a novel combination

dc.contributor.departmentKUH (Koç University Hospital)
dc.contributor.departmentSchool of Medicine
dc.contributor.kuauthorÇağlayan, Benan Niku
dc.contributor.kuauthorİliaz, Sinem
dc.contributor.kuauthorKarataş, Ferhan
dc.contributor.kuauthorUzel, Fatma Işıl
dc.contributor.schoolcollegeinstituteKUH (KOÇ UNIVERSITY HOSPITAL)
dc.contributor.schoolcollegeinstituteSCHOOL OF MEDICINE
dc.date.accessioned2024-11-09T12:40:15Z
dc.date.issued2020
dc.description.abstractCoronavirus disease 2019 (COVID-19) has become a game changer in many aspects of clinical practice. Acute exacerbations of idio-pathic pulmonary fibrosis (IPF) are known as serious events, which can reach a mortality rate of 50%, where viral infections may play a role. We describe the case of a 64-year-old male patient with a diagnosis of IPF under antifibrotic treatment for 1 year; the patient tested positive for COVID-19 with polymerase chain reaction test of the nasopharyngeal swab, and his chest computed tomography results were compatible with COVID-19 pneumonia described in the literature as well as the findings compatible with interstitial lung disease. The patient was successfully treated in the pulmonology ward according to official guidelines about COVID-19 along with antifibrotic treatment and required only a short course of oxygen therapy. We experienced no drug interactions, serious side effects, or complications during treatment. The patient was discharged after 1 week, and he is still in a good condition after 3 weeks. COVID-19 pneumonia in a patient with IPF who survived under antifibrotic treatment without serious deterioration is a new experience. Such cases will probably change our perspective in treating patients with IPF.
dc.description.fulltextYES
dc.description.indexedbyWOS
dc.description.indexedbyScopus
dc.description.indexedbyPubMed
dc.description.issue6
dc.description.openaccessYES
dc.description.publisherscopeNational
dc.description.sponsoredbyTubitakEuN/A
dc.description.sponsorshipN/A
dc.description.versionPublisher version
dc.description.volume21
dc.identifier.doi10.5152/TurkThoracJ.2020.20123
dc.identifier.eissn2149-2530
dc.identifier.embargoNO
dc.identifier.filenameinventorynoIR02567
dc.identifier.quartileN/A
dc.identifier.urihttps://hdl.handle.net/20.500.14288/2172
dc.identifier.wos600070300014
dc.keywordsCOVID-19
dc.keywordsExacerbation
dc.keywordsIdiopathic pulmonary fibrosis
dc.language.isoeng
dc.publisherAves
dc.relation.grantnoNA
dc.relation.ispartofTurkish Thoracic Journal
dc.relation.urihttp://cdm21054.contentdm.oclc.org/cdm/ref/collection/IR/id/9206
dc.subjectMedicine
dc.subjectRespiratory system
dc.titleCOVID-19 pneumonia and idiopathic pulmonary fibrosis: a novel combination
dc.typeJournal Article
dspace.entity.typePublication
local.contributor.kuauthorUzel, Fatma Işıl
local.contributor.kuauthorİliaz, Sinem
local.contributor.kuauthorKarataş, Ferhan
local.contributor.kuauthorÇağlayan, Benan Niku
local.publication.orgunit1SCHOOL OF MEDICINE
local.publication.orgunit1KUH (KOÇ UNIVERSITY HOSPITAL)
local.publication.orgunit2KUH (Koç University Hospital)
local.publication.orgunit2School of Medicine
relation.isOrgUnitOfPublicationf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isOrgUnitOfPublicationd02929e1-2a70-44f0-ae17-7819f587bedd
relation.isOrgUnitOfPublication.latestForDiscoveryf91d21f0-6b13-46ce-939a-db68e4c8d2ab
relation.isParentOrgUnitOfPublication055775c9-9efe-43ec-814f-f6d771fa6dee
relation.isParentOrgUnitOfPublication17f2dc8e-6e54-4fa8-b5e0-d6415123a93e
relation.isParentOrgUnitOfPublication.latestForDiscovery055775c9-9efe-43ec-814f-f6d771fa6dee

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
9206.pdf
Size:
946.75 KB
Format:
Adobe Portable Document Format